In addition to these findings from the immunohistochemistry study in GBM patient sections, we further demonstrated that a knockdown of PDCD10 in glioblastoma cells promoted malignant behaviors of tumor cells in vitro and stimulated tumor growth in vivo by triggering EphB4 kinase [21]. This evidence concerns the gene PDCD10 and glioblastoma.